Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1 Breast 1

Conditions

Lung Neoplasms 3644 Carcinoma, Non-Small-Cell Lung 3585 Small Cell Lung Carcinoma 576 Breast Neoplasms 419 Neoplasms 299 Adenocarcinoma of Lung 249 Colorectal Neoplasms 222 Melanoma 201 Mesothelioma, Malignant 183 Pancreatic Neoplasms 179 Prostatic Neoplasms 178 Brain Neoplasms 178 Head and Neck Neoplasms 173 Neoplasm Metastasis 167 Ovarian Neoplasms 153 Esophageal Neoplasms 152 Mesothelioma 145 Colonic Neoplasms 140 Stomach Neoplasms 139 NSCLC 115 Pleural Effusion, Malignant 114 Carcinoma, Renal Cell 109 Urinary Bladder Neoplasms 105 Disease 96 Sarcoma 85 Uterine Cervical Neoplasms 82 Thymoma 79 Liver Neoplasms 77 Motor Activity 75 Squamous Cell Carcinoma of Head and Neck 72

Interventions

atezolizumab 1 alectinib 1 Vemurafenib 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Genomic Instability × Thoracic × Clear all

NCT02314481 2026-05-04

DARWINII

University College, London

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Genomic Instability

Data powered by HemOnc (CC BY 4.0) Colophon ⚡